Skip to main content

Table 3 Comparison of patient characteristics

From: Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial

  

No LLLT/PBMT

(n = 32)

LLLT/PBMT

(active or placebo)

(n = 51)

p-value

Gender

Female

6 (18.8%)

2 (3.9%)

0.05006

 

Male

26 (81.3%)

49 (96.1%)

 

Age (years)

Mean ± SD

57.5 (52.7–64.5)

59 (53–65)

0.97

Tumour Location

Oral cavity

8 (25%)

9 (17.6%)

0.60

 

Hypopharynx

8 (25.0%)

11 (21.6%)

 

Oropharynx

16 (50.0%)

31 (60.8%)

 

TNM classification

T1

5 (15.6%)

2 (3.9%)

0.20

 

T2

8 (25.0%)

16 (31.4%)

 

T3

10 (31.2%)

24 (47.1%)

 

T4a

7 (21.9%)

6 (11.8%)

 

T4b

2 (6.2%)

3 (5.9%)

 

N0

3 (9.4%)

12 (23.5%)

0.25

N1

3 (9.4%)

3 (5.9%)

 

N2

24 (75.0%)

32 (62.7%)

 

N3

1 (3.1%)

4 (7.8%)

 

Nx

1 (3.1%)

0 (0%)

 

Histologic differentiation

Well-differentiated

15 (46.9%)

21 (41.2%)

0.95

 

Unknown

2 (6.3%)

4 (7.8%)

 

Moderately differentiated

12 (37.5%)

19 (37.3%)

 

Poorly differentiated

3 (9.4%)

7 (13.7%)

 

Smoking status

Never-smokers

4 (12.5%)

8 (15.7%)

0.94

 

Smokers

28 (87.5%)

43 (84.3%)

 

During CRT

Smoking cessation

1 (7.7%)

7 (38.9%)

0.095

 

Active smokers

12 (92.3%)

11 (61.1%)

 

Alcohol consumption

No

9 (28.1%)

13 (25.5%)

0.64

 

Unknown

2 (6.3%)

1 (2.0%)

 

Yes

21 (65.6%)

37 (72.5%)

 

During CRT

Alcohol withdrawal

3 (33.3%)

5 (25.0%)

0.99

 

Active alcohol use

6 (66.7%)

15 (75.0%)

 

Feeding

Enteral feeding

4 (12.5%)

5 (9.8%)

0.84

 

Liquid diet

0 (0%)

1 (2.0%)

Minced food

7 (21.9%)

16 (31.4%)

(binary

Unspecified

2 (6.3%)

0 (0%)

data)

Solid diet

19 (59.4%)

29 (56.9%)

 
  1. TNM Tumour/Node/Metastasis.
  2. CRT Chemoradiotherapy.